Squarepoint Ops LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2025 Nov 14, 2025	BUY	$11.93 - $21.97 $1.01 Million - $1.86 Million	84,700 Added 304.68%	112,500 $2.17 Million
Q2 2025 Aug 27, 2025	BUY	$17.1 - $63.66 $64,980 - $241,908	3,800 Added 15.83%	27,800 $475,000
Q2 2025 Aug 14, 2025	BUY	$17.1 - $63.66 $64,980 - $241,908	3,800 Added 15.83%	27,800 $475,000
Q1 2025 Aug 27, 2025	SELL	$63.82 - $127.89 $242,516 - $485,982	-3,800 Reduced 13.67%	24,000 $1.53 Million
Q1 2025 May 15, 2025	SELL	$63.82 - $127.89 $791,368 - $1.59 Million	-12,400 Reduced 34.07%	24,000 $1.53 Million

Q4 2024 Feb 14, 2025	BUY	$104.54 - $137.94 $3.55 Million - $4.69 Million	34,000 Added 1416.67%	36,400 $4.43 Million
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $298,392 - $376,200	2,400 New	2,400 $299,000

406

83.7M

5.27M

5.94M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.